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A (CoA), classified as Pantothenate Kinase Associated Neurodegen-
eration (PKAN), resulted in identification of the enzyme mitochon-
drial form, PANK 2, that was distinguished in regulatory properties
from the cytosolic CoA synthesis from pantothenic acid (PA).
Coenzyme biosynthesis in CNS structures is determined by PA uptake
from circulating blood and biotransformation to intermediate
products, such as 4′-phospho-PA (PPA) and 4′-phospho-pantetheine
(PPN). For the mitochondrial neuronal compartment, the pathway
remains to be open for CoA biosynthesis from pantetheine (PN),
exactly, the oxidized form, pantethine (PT). The experiments with
intraperitoneal injections of [3H]-PA or [3H]-PT at dose of 1.1 mCi/kg
to albino Wistar rats showed active transport (uptake) of both forms
of CoA precursors by the large hemispheres that reached a maximum
by 180 min (PT treatment) and 12 h (PA administration). The PT
treatment was accompanied by radionuclide accumulation predomi-
nantly in the postmitochondrial fraction inwhich HPLC identified PPA
as the main form (other PA components, PN, PPN and low amounts of
CoA). The predominant metabolite in perchlorate mitochondrial
extracts was PPA and, probably, dephospho-CoA. The [3H]-PA
administration caused biotransformation of the radionuclide to CoA
whose fraction reached 46% after 30 min and 72% after 12 h of the
total radioactivity level in perchlorates, whereas the radionuclide was
not deposited in the mitochondrial PPA and PPN fractions and the
post-mitochondrial supernatant. The PT administration can be
suggested to cause PPA accumulation while the PA treatment — to
form CoA in the CNS, which reflects the peculiarities of their
neuroprotective activity. A high level of uptake and biotransformation
of CoA biosynthetic precursors was found in the hippocampus.
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Mitochondrial dysfunction is emerging as a key cause factor for
therapy-resistant forms of severe epilepsy [1]. A broad variety of
mitochondrial DNA mutations [2] is associated with mitochondrial
respiratory chain failure, consequent mitochondrial dysfunction and
different epileptic phenotypes. It is not yet clear whether dysfunction
of mitochondrial oxidative phosphorylation has a causative role in
temporal lobe epilepsy (TLE) with hippocampal sclerosis. In this study
we compared amount of multiple deletions of the mtDNA in four
different hippocampal subfields (CA1, CA3, AD and PH) in patients
with TLE, by using a long range PCR technique. The samples were
obtained after epilepsy surgery of 20–40 years old patients, belonging
to two different TLE subgroups. The first group is represented by 21 TLE
patients whom developed Ammon's horn sclerosis — the most
common type of neuropathological damage in individuals with TLE,
characterized by neuronal cell loss in the hippocampus. The second
group includes 8 TLE patients, with identified brain lesion as primary
cause of epilepsy. It is well known that these patients usually do not
develop hippocampal degeneration. We found a significant difference
in themtDNAdeletion amounts between the two groups of patients, in
each of the four hippocampal subfields. Our findings demonstrate that,
in difference to lesion TLE patients, mtDNA deletions are typical for
patients with AHS, especially, in the CA3 region. Though, it is known
that multiple deletions are accumulating with age, in this study we
demonstrate that in AHS patientsmultiple deletions can be detected in
early stage of life. We propose that mtDNA deletionsmight be relevant
for seizure generation in AHS patients.
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Diabetic sensory neuropathy is a major complication of type 1 and
2 diabetes that leads to distal loss of nerve fibers. Impairments in
mitochondrial function have been proposed to play a role in the
etiology of the neurodegeneration. We tested the hypothesis that
mitochondrial dysfunction in sensory neurons in type 1 diabetes is
due to abnormal activity of the respiratory chain and an altered
mitochondrial proteome. Rates of oxygen consumption in mitochon-
dria from dorsal root ganglia (DRG) of age-matched control, 12–22
week streptozotocin (STZ)-induced type 1 diabetic rats and diabetic
rats treated with insulin were measured by OROBOROS oxygraph.
Rates of coupled respiration with pyruvate+malate (P+M; full
respiratory chain) and with ascorbate+TMPD (Asc+TMPD; Com-
plex IV) in lumbar DRG were unchanged after 12 weeks of diabetes.
By 22 weeks of diabetes, respiration with P+M was significantly
decreased by 31–44% and with Asc+TMPD by 29–39% compared to
control. Attenuated mitochondrial respiratory activity of STZ-diabetic
rats was significantly improved by insulin treatment that did not fully
correct other indices of diabetes. Enzymatic activities of mitochon-
drial complexes I and IV and the Krebs cycle enzyme, citrate synthase,
were decreased in mitochondria from DRG of 22 week STZ-diabetic
rats compared to control. Quantitative proteomic analysis using 13C6-
Lys and 13C6,15N4-Arg labeled mitochondria as isotope tagged internal
standards indicated that proteins associated with oxidative phos-
phorylation and the citric acid cycle were significantly down-
regulated. Western blotting of DRG samples confirmed the proteomic
analysis results for a specific subset of proteins and revealed reduced
activation of AMP kinase (AMPK) coupled with diminished expres-
sion of peroxisome proliferator-activated receptor gamma coactiva-
tor-1 alpha (PGC-1α). In vitro confocal imaging studies with neurons
from diabetic rats using TMRM+ in sub-quench mode showed
mitochondria in axons to be depolarized and to exhibit an aberrant
hyperpolarization in response to oligomycin. Mitochondrial dysfunc-
tion in sensory neurons in type 1 diabetes was associated with
impaired rates of respiratory chain activity and modified adaption to
hyperpolarization. The abnormal mitochondrial activity correlated
with a down-regulation of an array of mitochondrial proteins that
was associated with lowered activation status of the up-stream
regulators of mitochondrial biogenesis, AMPK and PGC-1α.
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